Beijing Tong RenTang Stock Hits Day Low Amid Price Pressure at CNY 28.51

Beijing Tong RenTang Co., a prominent player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline today, with its stock price dropping by 3.64% on March 23, 2026. The stock reached an intraday low of CNY 28.51, reflecting ongoing challenges in its performance metrics. Over the past year, Beijing Tong RenTang has faced significant headwinds, with a total return of -22.44%, contrasting sharply with the China Shanghai Composite's gain of 13.33% during the same period. The company's performance has been consistently below par, as evidenced by a -43.59% return over the last three years. Financial indicators reveal a concerning trend, with net sales growing at an annual rate of only 7.89% and operating profit at 7.39% over the past five years. The company has reported negative results for six consecutive quarters, and its return on capital employed (ROCE) stands at a low 10.16%. Additionally, the inventory turnover ratio is at 0.97 times, indicating potential inefficiencies in inventory management. With a market capitalization of CNY 41,967 million, Beijing Tong RenTang continues to navigate a challenging landscape in the pharmaceutical industry.